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Human TR4 orphan receptor (TR4) can modulate the
transcriptional activity of the reporter gene containing
an AGGTCA direct repeat-hormone response element.
Here we studied the potential role of TR4 in human
HaCaT keratinocytes. Using a chloramphenicol acetyl-
transferase reporter gene assay, it was shown that TR4
can suppress retinoic acid-induced transactivation by
47.3% in human HaCaT keratinocytes. Electrophoretic
mobility shift assay indicated that this suppression may
be due to TR4 binding with higher affinity to the
retinoic acid response element than retinoid receptors.
Western blot analysis further suggested that retinoic
Members of the steroid/thyroid hormone receptorsuperfamily are transcription factors that regulatethe expression of target genes by binding to theirhormone response elements (Evans, 1988; Tsaiand O’Malley, 1994). Some members of this
family are putative receptors, designated as orphan receptors, having
unidentified ligands (O’Malley and Conneely, 1992; Enmark and
Gustafsson, 1996). The human TR4 orphan receptor (TR4) was
isolated by our laboratory from human prostate and testis libraries,
using degenerative polymerase chain reaction cloning (Chang et al,
1994). From cDNA sequence analysis, human TR4 consists of 615
amino acid residues and its calculated molecular weight is 67.3 kDa.
The amino acid sequence of TR4 is closely related to that of TR2,
one of the first identified orphan receptors (Chang et al, 1989),
suggesting that TR2 and TR4 orphan receptors form a unique
subclass among the steroid/thyroid hormone receptor superfamily.
Based on the sequence of P box, which is three amino acid residues
in the first zinc-finger of the DNA-binding domain, it has been
speculated that TR4 belongs to the estrogen receptor/thyroid
hormone receptor subfamily, which can bind to AGGTCA direct
repeats (direct repeats; AGGTCA (n)x AGGTCA, x 5 0–6). We
have identified a TR4 response element containing an imperfect
direct repeat 2 in the SV40 major late promoter (Lee et al, 1995).
Using a chloramphenicol acetyltransferase (CAT) reporter gene
assay, we found that TR4 can induce the transcriptional activity of
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acid can increase the expression of TR4 protein in
human HaCaT keratinocytes, indicating that TR4 acts
as a negative feedback modulator for retinoic acid
action. Interestingly, TR4 expression is increased in
normal human keratinocytes when substituting a low
calcium medium with a high calcium medium.
Together, our data suggested, for the first time, that
an orphan receptor, such as TR4, may play an import-
ant part in retinoid-mediated signaling pathways in
human keratinocytes, providing a new insight into
keratinocyte biology. Keywords: differentiation/TR4/
vitamin A. J Invest Dermatol 112:426–431, 1999
the reporter gene containing a direct repeat four hormone response
element and the intronic enhancer of the human ciliary neuro-
trophic factor receptor gene (Lee et al, 1997; Young et al, 1997).
TR4, therefore, could modulate the ligand-mediated steroid/
thyroid hormone receptor action.
Among the ligands for steroid/thyroid receptor superfamily,
retinoic acid (RA) and vitamin D are especially important modu-
lators for human keratinocyte growth and differentiation (Bikle
and Pillai, 1993; Fisher and Voorhees, 1996). RA inhibits differenti-
ation of cultured human keratinocytes through suppression of
expression of differentiation-markers, such as keratins 1 and 10
(Fuchs and Green, 1981) and filaggrin (Asselineau et al, 1990).
Vitamin D at concentrations higher than 10–8 M markedly inhibits
keratinocyte growth and enhances differentiation (Itin et al, 1994).
Considering these findings, it is of interest to study the expression
and function of TR4 in human keratinocytes. In this study, we
used human HaCaT keratinocytes as well as normal primary human
keratinocytes.
Using a CAT reporter gene assay through their endogenous
cognate receptors, we demonstrated here that TR4 suppresses RA-
mediated, but not vitamin D mediated transcriptional activity in
human HaCaT keratinocytes. We also demonstrated that the
expression level of TR4 is increased by RA in HaCaT keratinocytes,
indicating that TR4 acts as a negative feedback modulator for RA
action in human keratinocytes. Finally, we were able to show that
TR4 expression is increased in normal human keratinocytes by
switching from a low calcium medium to a high calcium medium.
MATERIALS AND METHODS
Cell culture Human HaCaT keratinocytes (originated in Dr. Norbert
Fusenig’s laboratory), an immortalized cell line, were cultured in Dulbecco’s
modified Eagle’s medium plus 10% fetal bovine serum and 100 U penicillin/
streptomycin per ml (Boukamp et al, 1988; Pincelli et al, 1997). For RA
and vitamin D treatment, we used Dulbecco’s modified Eagle’s medium
containing charcoal-stripped fetal bovine serum. MCF-7 cells, a breast
cancer cell line, were also cultured in Dulbecco’s modified Eagle’s medium
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plus 10% fetal bovine serum and 100 U penicillin/streptomycin per ml.
Neonatal foreskins were obtained with informed consent according to the
regulations of the University of Rochester Human Subjects Review Board.
Keratinocyte cultures were established as described previously (Haake and
Cooklis, 1997), and cultured in keratinocyte growth medium (KGM)
containing 30 µg bovine pituitary extract per ml, 0.1 ng human epidermal
growth factor per ml, 5.0 µg insulin per ml, and 0.5 µg hydrocortisone
per ml (KGM; Clonetics, Palo Alto, CA). For each experiment, we used
the third passage of foreskin keratinocytes. When we examined TR4
expression change with the Ca21 switch in the medium, we used KGM
without bovine pituitary extract, human epidermal growth factor, insulin,
and hydrocortisone.
Polyclonal antibodies against TR4 To obtain a large amount of TR4
antigen, the Escherichia coli pET expression system was utilized. The
expression of the full-length TR4 was performed according to the
manufacturer’s instruction (Novagen, Madison, WI) with the addition of
six consecutive histidine residues at the N-terminal TR4. The lysates were
centrifuged at 20,800 3 g for 20 min at 4°C. The extract was analyzed
on sodium dodecyl sulfate–polyacrylamide gel electrophoresis followed by
Coomassie Blue staining, or purified by a one-step metal chelating
chromatography (Novagen). The antigen was prepared by directly cutting
from the sodium dodecyl sulfate–polyacrylamide gel electrophoresis, emulsi-
fied with Freund’s complete adjuvant, and then injected into rabbits.
Plasmids The pCMX-TR4 plasmid was constructed as described previ-
ously (Lee et al, 1995). To construct pRARβ-CAT, we synthesized
the double-stranded oligonucleotides of RA response element (RARE)
(GGTTCAccgaaAGTTCA) from the promoter region of RA receptor β
(RARβ) (Sucov et al, 1990) and ligated it into the BglII site of pCAT
promoter vector (Promega, Madison, WI). The reporter plasmid P450cc24-
CAT, which contains 59-flanking region (–2200 to 1188) of the rat vitamin
D3 24-hydroxylase gene, was kindly provided by Dr. Y. Kato (Ohyama
et al, 1994). The expression plasmids, pSG5-RARα and pCMX-retinoid
X receptor α (RXRα), were kindly provided by Dr. Ronald M. Evans
(The Salk Institute for Biological Studies, Howard Hughes Medical
Institute, La Jolla, California).
Nuclear extracts Nuclear extracts were prepared following a mini-
extract procedure (Lee et al, 1988). Briefly, the cells were harvested and
lysed by pushing through a 25-gauge hypodermic needle. The nuclear
pellet was resuspended in buffer C [500 mM NaCl, 20 mM HEPES, 25%
glycerol, 1.5 mM MgCl2, 0.2 mM ethylenediamine tetraacetic acid (EDTA),
0.5 mM dithiothreitol] and incubated on a rotating wheel for 30 min at
4°C. The nuclear debris was eliminated by centrifugation for 30 min and
supernatants were dialyzed for 2 h against buffer D (20 mM HEPES,
20% glycerol, 100 mM KCl, 0.2 mM EDTA, 0.5 mM dithiothreitol).
Protein concentration was determined using Bradford reagent (Bio-Rad,
Hercules, CA).
Coupled in vitro transcription and translation The expression
plasmids, pCMX-TR4, pSG5-RARα, and pCMX-RXRα, were in vitro
transcribed and translated by the rabbit reticulocyte-based transcription/
translation kit (TNT coupled reticulocyte lysate system) (Promega) as
described previously (Lee and Chang, 1995).
Transient transfection Polybrene with dimethylsulfoxide shock was
used for transient transfection into HaCaT keratinocytes, as reported
previously (Jiang et al, 1991). Four micrograms of CAT constructs were
cotransfected with 1–2 µg of pCMX-TR4. To normalize the transfection
efficiency, 1 µg of β-galactosidase expression vector, pCMVβ (Clontech),
was cotransfected in all experiments. MCF-7 cells were transfected using
a modified calcium phosphate precipitation method (Mizokami and
Chang, 1994).
CAT assay Twenty-four hours after transfection, we treated cells with
10–6 or 10–8 M all-trans retinoic acid (atRA), 10–7 or 10–10 M 1,25-
dihydroxyvitamin D3 [1,25-(OH)2D3], or ethanol as a vehicle. At 48 h
after transfection, the cells were washed twice with phosphate-buffered
saline (–) and harvested. The cells were lysed by three cycles of freeze–
thawing. The lysates were centrifuged for 5 min at 20,800 3 g. To
inactivate the internal inhibitory fraction for CAT activity, the supernatants
were incubated at 57°C for 10 min and used for the CAT reaction. The
reaction products were dissolved with ethyl acetate and applied to thin-
layer chromatography using a solvent of 95% chloroform and 5% methanol.
CAT activity was measured by PhosphorImager (Molecular Dynamics,
Sunny Vale, CA).
Electrophoretic mobility shift assay Electrophoretic mobility shift
assay analysis was performed as described previously (Cooney et al,
1993). The oligonucleotides were 59 end labeled with a γ-32P adenosine
triphosphate (specific activity 5 6000 Ci per mmol) (New England Nuclear,
Beverly, MA) by T4 polynucleotide kinase to 2–8 3 108 cpm per µg.
Labeled oligonucleotides (0.1 or 0.001 ng) were incubated with in vitro
translated proteins, in the presence or absence of unlabeled oligonucleotide
competitor, for 15 min at room temperature. The binding buffer contained
25 mM Tris–HCl (pH 8.0), 10% glycerol, 50 mM KCl, 2 mM EDTA,
0.05% TritonX-100, 5 mM dithiothreitol, 1% β-mercaptoethanol, 5 ng
per ml bovine serum albumin, 1.5 units per ml aprotinin, and 1 µg
poly(dI.dC) (Pharmacia, Piscataway, NJ). DNA–protein complexes were
resolved on a 5% nondenaturing polyacrylamide gel at 4°C in 0.5 3 TBE
buffer (1 3 TBE 5 0.09 M Tris-borate and 0.002 M EDTA). Gels were
fixed in 50% ethanol and 10% acetic acid for 30 min, followed by drying.
The radioactive gels were analyzed by autoradiography. As a probe, we
used the double-stranded oligonucleotides of RARE (GGTT-
CAccgaaAGTTCA) from the promoter region of RARβ (Sucov et al, 1990).
Western blot analysis Before treatment with atRA and 1,25-(OH)2D3,
we maintained the cells for 1 wk in Dulbecco’s modified Eagle’s medium
containing 10% charcoal-stripped fetal bovine serum. Then 10–6 and
10–8 M atRA or 10–7 and 10–10 M 1,25-(OH)2D3 were added to
subconfluent HaCaT keratinocytes cultured on 100 mm dishes. At the
indicated time after treatment, keratinocytes were washed twice with ice-
cold phosphate-buffered saline (–) and extracted with an extraction buffer
(1% NP-40, 1 µg per ml aprotinin, and 400 mM NaCl in 20 mM HEPES,
pH 7.2). Protein concentration was determined using Bradford reagent
(Bio-Rad). Twenty micrograms per lane of nuclear extract and cell lysate
protein from keratinocytes were loaded on to 10% polyacrylamide gel, and
transferred to an Immobilon-P membrane (Millipore, Bedford, MA). The
membrane was soaked overnight in 5% skimmed milk in phosphate-
buffered saline (–)/0.05% Tween at 4°C, and then incubated with anti-
TR4 polyclonal antibodies at a 1:5000 dilution in 5% skimmed milk in
phosphate-buffered saline (–)/0.05% Tween for 2 h at room temperature.
After being washed three times at intervals of 10 min with phosphate-
buffered saline (–)/0.05% Tween, the membranes were incubated with
alkaline phosphatase-conjugated goat anti-rabbit IgG (Bio-Rad) at a 1:2000
dilution for 1 h at room temperature. Detection was performed with
Alkaline Phosphatase Conjugate Substrate Kit (Bio-Rad). Western blot
analysis for MCF-7 cells was performed using the same procedure. For
analysis of the expression level of TR4 protein after Ca21 switch, normal
human keratinocytes were first cultured in KGM with 0.15 mM Ca21.
When the keratinocyte cultures reached subconfluency, the Ca21 concen-
tration was increased to 1.8 mM. The cells were harvested at 0, 24, 48,
and 72 h after increasing Ca21 concentration. The cells were pelleted by
centrifugation, and lysed in 2% sodium dodecyl sulfate. The lysate was
sonicated and the protein concentration was measured (Gibson et al, 1996).
Twenty micrograms of protein were subjected to western blot analysis as
described above. The expression amounts of TR4 were quantitated by
collage image analysis software (Fotodyne, Hartland, WI).
RESULTS
TR4 protein is expressed in HaCaT keratinocytes Western
blot analysis was performed to examine whether TR4 is expressed
in human HaCaT keratinocytes. In vitro translated TR4 protein
was used as a positive control (Fig 1a, lane 2). The TR4 protein
with the molecular weight of 67 kDa was detected with polyclonal
antibodies against TR4 in the cell lysates (Fig 1a, lane 1) as well
as in the nuclear extracts (Fig 1b). With preimmune serum, these
bands were not detected (data not shown). The specificity of this
immunoblot with polyclonal antibodies against TR4 was confirmed
in western blot analysis of MCF-7 cells transiently transfected with
pCMX-TR4 or pCMX (mock). The 67 kDa band was detected
only in the cells transfected with pCMX-TR4 (Fig 1c).
TR4 suppresses RA-induced transactivation in HaCaT
keratinocytes To study the potential roles of TR4 in ker-
atinocytes, we used CAT reporter gene assays to examine the effect
of TR4 on RA-induced and vitamin D-induced transactivation in
HaCaT keratinocytes. Previously, it was reported that keratinocytes
express endogenous retinoid receptors capable of specifically activat-
ing RARE but not retinoid X response element (Xiao et al, 1995).
Therefore, to assay the RA-induced transactivation, we used the
pRARβ-CAT reporter plasmid, which contains the synthetic
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Figure 1. TR4 protein is expressed in HaCaT keratinocytes. (a)
Twenty micrograms of cell lysate (lane 1) from subconfluent HaCaT
keratinocytes, and 5 µl of TNT-translated TR4 (lane 2) were subjected to
sodium dodecyl sulfate–polyacrylamide gel electrophoresis and western
blotting, followed by immunoblotting with polyclonal antibodies against
TR4. (b) Twenty micrograms of nuclear extracts from HaCaT keratinocytes
were treated as (a). (c) Twenty micrograms of cell lysates from MCF-7
cells transiently transfected with pCMV (lane 1) or pCMV-TR4 (lane 2)
were treated as (a). Bars on the left margin represent the molecular mass
marker in kilodaltons.
RARE (GGTTCAccgaaAGTTCA) sequence obtained from the
promoter region of RARβ (Sucov et al, 1990). The reporter
plasmid for a vitamin D-induced transactivation assay was P450cc24-
CAT, which contains the 59-flanking region (–2200 to 1188) of
the rat vitamin D3 24-hydroxylase gene (Ohyama et al, 1994).
Without transfection of exogenous RA receptors and vitamin D
receptor, we analyzed ligand-induced transactivation of CAT
reporter plasmid via endogenous cognate receptors in HaCaT
keratinocytes. We observed a 9.9-fold induction with a pharmaco-
logic concentration (10–6 M) of atRA (Rollman and Vahlquist,
1983) in the absence of TR4 expression vector (Fig 2, lane 1 vs
2). Co-transfection of 1 and 2 µg of pCMX-TR4 decreased this
CAT activity by 23.3% and 47.3%, respectively (Fig 2, lanes 3
and 4). Although we detected a 38.8-fold induction with a
supraphysiologic concentration (10–7 M) of 1,25-(OH)2D3 (Itin
et al, 1994) without exogenous TR4, cotransfection of 2 µg of
pCMX-TR4 did not have a significant effect on CAT activity
(Fig 2, lanes 9–11). In addition, we examined the effect of TR4
on these CAT activities induced by the physiologic concentration
of atRA (10–8 M) (De Leenheer et al, 1982) and 1,25-(OH)2D3
(10–10 M) (Bouillon, 1983). Likewise, cotransfection of 1 and
2 µg of pCMX-TR4 reduced the 10–8 M atRA-induced CAT
activity by 45.0% and 59.7%, respectively (Fig 2, lanes 5–8);
however, 10–10 M 1,25-(OH)2D3-induced transactivation could
not be significantly changed by the transfection with 2 µg of
pCMX-TR4 (Fig 2, lanes 12–14). Co-transfection of pCMX-
TR4 had no effect on the basal (ligand-independent) CAT activity
(data not shown). These results indicated that TR4 can suppress
RA-induced, but not vitamin D-induced transactivation in human
HaCaT keratinocytes.
Figure 2. TR4 can suppress RA-induced pRARb-CAT, but not
vitamin D-induced P450cc24-CAT reporter activity. The reporter
plasmids (4 µg of pRARβ-CAT and P450cc24-CAT) were transfected
into HaCaT keratinocytes in the presence of the indicated amount of
pCMX-TR4 plasmid. The cells were treated with 10–6 and 10–8 M atRA,
10–7 and 10–10 M 1,25-(OH)2D3, or ethanol only, as indicated. CAT
activities were determined and expressed as relative activity of each reporter
in the presence of atRA or 1,25-(OH)2D3 but in the absence of pCMX-
TR4 plasmid. Error bars, mean 6 SD from three independent experiments.
*Significant difference from the control (lanes 2 or 6), p , 0.01.
TR4 binds to RARE with higher affinity than RAR/
RXR To test whether heterodimer formation between TR4 and
RAR or RXR could be the possible mechanism for TR4 suppres-
sion of RA-induced transactivation, we performed electrophoretic
mobility shift assays. The RARE sequence, GGTTCAccgaaAGTT-
CA, obtained from the promoter region of RARβ (Sucov et al,
1990) was used as a probe. In vitro translated TR4 orphan receptor
binds specifically to RARE with one clear band shift (Fig 3a, lane
3 vs lane 9; open triangle). This shifted band could be competed out
by the further addition of a 100-fold excess of unlabeled RARE
(data not shown). When in vitro translated TR4 was replaced by
either in vitro translated RARα (Fig 3a, lane 1) or RXRα (Fig 3a,
lane 2), no specific band shift was observed. A clear band shift
appeared, however, when we added both in vitro translated RARα
and RXRα (Fig 3a, lane 4; closed arrow). This band was quite
different from that of the TR4-RARE complex, which migrates
at a much higher position (Fig 3a, lane 3 vs lane 4). When in vitro
translated TR4 was incubated together with in vitro translated
RARα/RXRα, two distinct shift bands could be observed, one
for TR4 and another for RARα/RXRα. There was no third shift
band of heterodimer between TR4 and RARα/RXRα (Fig 3a,
lanes 5–8). These data indicated no significant heterodimer forma-
tion between TR4 and RARα and/or RXRα. Next, we compared
the binding affinity of TR4 and RAR/RXR to RARE. Consistent
with Fig 3a, both in vitro translated TR4 and RARα/RXRα can
bind to 0.1 ng RARE (Fig 3b, lanes 1 and 2). When 0.001 ng
RARE probe was incubated with in vitro translated TR4 and
RARα/RXRα, however, only TR4 can bind to RARE (Fig 3b,
lane 3). These results suggest that TR4 can suppress RAR/RXR
activity through binding to RARE with a higher affinity than
RAR/RXR.
RA upregulates the expression level of TR4 protein in
HaCaT keratinocytes In order to investigate whether TR4 can
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Figure 3. TR4 does not form a heterodimer with RAR/RXR but
binds to RARE-RARb with higher affinity than RAR/RXR. (a) In
vitro translated TR4 (2 µl), RARα (2 µl), and RXRα (1 µl) were incubated
with 0.1 ng 32P-labeled RARE-RARβ oligomer and analyzed by an
electrophoretic mobility shift assay. The amount of TR4 was increased to
4 µl in lane 8. Rabbit reticulocyte lysate (2 µg) was used as a control (lane
9). The closed triangle indicates the RARE-protein complex formed by
RAR/RXR heterodimer, and the open triangle, by TR4. The gel was
exposed to a X-ray film overnight. (b) In vitro translated TR4 (2 µl),
RARα (2 µl), and RXRα (1 µl) were incubated with 0.1 ng 32P-labeled
RARE-RARβ oligomer and analyzed by an electrophoretic mobility shift
assay (lanes 1 and 2). The amount of 32P-labeled RARE-RARβ oligomer
was decreased to 0.001 ng in lane 3. The closed and open triangles indicate
the RARE–protein complex formed by RAR/RXR heterodimer and
TR4, respectively. The gel was exposed to a X-ray film for 5 d to detect
the band shift in lane 3.
act as a negative feedback regulator, we tested the effect of RA on
the expression level of TR4 protein using western blot analysis.
Following treatment with atRA at a pharmacologic concentration
(10–6 M), TR4 protein expression increased µ2.03-fold and 2.94-
fold at 12 and 24 h, respectively, suggesting that TR4 can act as a
strong negative feedback modulator for RA in human HaCaT
keratinocytes (Fig 4a). At a physiologic concentration of atRA
(10–8 M), the TR4 protein expression level in HaCaT keratinocytes
was increased to 2.56-fold and 3.15-fold at 6 and 12 h, respectively.
TR4 protein level returned to the basal level at 24 h, however
(Fig 4b). These results suggest that TR4 can function as a relatively
short-acting regulator at the physiologic concentration (10–8 M),
as compared with the pharmacologic concentration (10–6 M). For
the control, we also tested the effect of vitamin D. Results showed
that TR4 protein expression was not changed by treatment of
HaCaT keratinocytes with either the supraphysiologic or physio-
logic concentrations (10–7 or 10–10 M) of 1,25-(OH)2D3 (data
not shown).
TR4 protein level in normal human keratinocytes is
increased after switching from low to high Ca21 medium As
our data above indicated that TR4 could act as a negative feedback
regulator for RA signaling in keratinocytes and RA has been
implicated in major roles in cell differentiation, it was of interest
to determine whether there is any change of TR4 protein expression
in normal human keratinocytes by switching from low to high
Ca21 medium. At first, normal human keratinocytes were cultured
in KGM with 0.15 mM Ca21, which favors proliferation. When
the keratinocyte cultures reached subconfluency, the Ca21 concen-
tration was increased to 1.8 mM. The cells were harvested at 0,
24, 48, and 72 h after increasing Ca21 concentration, followed by
cell lysis and western blot analysis. At 24 and 48 h, TR4 protein
expression increased to 2.56-fold and 2.04-fold, respectively, relative
to low Ca21 cultures, indicating that TR4 in normal human
Figure 4. RA upregulates the expression level of TR4 protein. (a)
At 0, 12, 24, and 48 h after the addition of 10–6 M atRA, HaCaT
keratinocytes were harvested, lysed, and 20 µg of cell lysates were subjected
to western blot analysis. (b) At 0, 6, 12, and 24 h after the addition of
10–8 M atRA, HaCaT keratinocytes were subjected to western blot analysis
same as (a). Each upper graph is the quantitation of each band in the lower
immunoblot.
keratinocytes is upregulated by increasing the Ca21 concentration
in the medium (Fig 5).
DISCUSSION
RA is essential for normal skin development and function. RA
inhibits the induction of differentiation-related markers, such as
keratins 1 and 10 (Fuchs and Green, 1981), involucrin (Watt and
Green, 1981), filaggrin (Asselineau et al, 1990), and transglutaminase
(Goldsmith, 1983; Jetten, 1990; Polakowska et al, 1991) in human
keratinocytes cultured in vitro. Transgenic mouse models demon-
strated that targeted overexpression of dominant-negative RARα
in suprabasal keratinocytes may result in the defect of lipid deposition
and corneal barrier (Imakado et al, 1995), and that overexpression
of dominant-negative RARα in basal keratinocytes may also result
in dramatic suppression of epidermal maturation (Saitou et al, 1995).
Fisher and Voorhees, however, argued that these abnormalities
could be due to sequestration of RXR, because mutant RAR used
in these studies are capable of heterodimerizing with RXR (Fisher
and Voorhees, 1996). Thus, much remains to be learned about the
physiologic role of RA signaling in the skin.
In this study we proposed a new pathway to modulate RA
function in keratinocytes, providing a novel approach for studying
RA biology in human skin. The response of keratinocytes to RA
is largely different between in vitro culture and in vivo (Bikle and
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Figure 5. TR4 protein is increased by increasing Ca21 concentration
in the medium At 0, 24, 48, and 72 h after incubating in 1.8 mM Ca21,
normal human keratinocytes were harvested. Twenty micrograms of cell
lysates were subjected to western blot analysis. The upper graph is the
quantitation of each band in the lower immunoblot.
Pillai, 1993; Fisher and Voorhees, 1996) and modulation of epi-
dermal morphogenesis or differentiation by RA can also be different
between the fetal and the neonatal keratinocytes in the physiologic
skin equivalent (Haake and Cooklis, 1997). Our finding of bi-
directional regulation of TR4 and RA may represent a new
pathway, which may help to explain the diversity of RA function
in the skin.
Recently, rabbit TR4 was cloned from a rabbit heart cDNA
library and the data suggested that rabbit TR4 acts as a repressor
in the estrogen receptor-mediated signaling pathway in a bone
cell-specific manner (Harada et al, 1998). Our results showed that
TR4 in keratinocytes can suppress RA, but not vitamin D action.
The differential suppression of RA- versus vitamin D-mediated
transactivation in keratinocytes is different from our unpublished
data (Lee and Chang, submitted, 1999), which suggested that TR4
can repress the vitamin D-mediated transactivation in Chinese
hamster ovary cells. In addition, our observation (Lee and Chang,
in preparation) suggested that in vitro translated TR4 can bind to
vitamin D response element in an electrophoretic mobility shift
assay. The difference between the results in keratinocytes and
Chinese hamster ovary cells may be due to cell type specificity of
TR4 function. From recent studies regarding nuclear receptors, it
is speculated that the protein environment in the cell, including
the interaction with coactivators or corepressors, and basic transcrip-
tional apparatus, greatly influences nuclear receptor function. We
have cloned a possible TR4 associated protein gene by yeast two
hybrid system (Chang, unpublished data, 1999), which may be
useful to clarify this question.
From a clinical aspect, RA is widely used as a drug for many
skin diseases, such as psoriasis, hyperkeratosis, sun-damaged skin
(skin aging), and acne (Nagpal et al, 1996; Cunliffe et al, 1997;
Gilchrest, 1997). Because of mutual regulation between TR4 and
RA signaling, TR4 will be a potential target to study for elucidation
of pathologic mechanisms and may allow us to develop new
therapies for these skin diseases. For example, the expression level
of RAR is not altered in psoriasis (Elder et al, 1991), suggesting
that a regulator for RA responsiveness in the skin, such as TR4,
might be of importance for its pathogenesis.
In this report, we compared the effect of pharmacologic and
physiologic concentrations (10–6 M and 10–8 M) of RA on TR4
protein expression levels. At the physiologic concentration, the
TR4 level returned more quickly to the basal level than that at
the pharmacologic concentration. This relatively quick return might
be due to the negative autoregulation of atRA by enzymes, such
as lecithin:retinol acyltransferase and atRA 4-hydroxyrase (Fisher
and Voorhees, 1996). Together, these results suggest that TR4 may
act as a relatively short-acting negative feedback regulator at the
physiologic concentration of atRA, compared with that at the
pharmacologic concentration. From our results, 10–6 and 10–8 M
RA differentially modulate TR4 protein expression level. Recently
it has been shown that 10–6 and 10–8 M RA differentially regulate
transglutaminase in human keratinocytes (Gibson et al, 1998).
Although, among RARs, nearly 90% is RARγ with 10% RARα
in the epidermis (Fisher et al, 1994), we used RARα/RXRα to
compare the binding affinity of TR4 and RAR/RXR with the
synthetic RARE, obtained from the promoter region of RARβ
(Fig 3). Based on the finding that RARα, β, and γ bind with
similar affinities to this response element (Vasios et al, 1991), our
results, however, can indicate that TR4 binds to RARE with
higher affinity than RAR/RXR.
The increase in the TR4 level by Ca21 switch indicates that
TR4 could be involved in keratinocyte terminal differentiation. It
is reasonable to speculate that TR4 may influence differentiation
by inhibiting RA signaling, as RA causes suppression of terminal
differentiation. In addition, TR4 may regulate directly the expres-
sion of differentiation-related genes. Alternatively, because TR4
acts as a negative feedback suppresser for RA, TR4 might silently
maintain the homeostasis of keratinocytes. The significance of these
observations, however, remains to be investigated further. In
particular, the identification of the true ligands for TR4 would
facilitate new approaches to this question.
In epidermis with differentiation, calcium concentration is low
in the basal and spinous layers, but increases to its highest level in
the granular layers (Bikle and Pillai, 1993). This gradient in vivo
indicates an important role of calcium in keratinocyte differenti-
ation. The calcium switch in the medium, however, does not
recapitulate the fully differentiated state characteristic of skin
in vivo. Additionally, as mentioned above, the effect of RA on
differentiation markers is different between in vitro culture and
in vivo (Rosenthal et al, 1990, 1992; Fisher and Voorhees, 1996),
indicating that responses of in vitro keratinocytes may not always
be true in vivo. Therefore, the function and regulation of TR4
during RA treatment and differentiation needs to be further
investigated by in vivo studies. We, however, believe that our
discovery of the novel negative regulation of retinoid action in
keratinocytes in vitro is unique and significant.
In conclusion, our data demonstrated that an orphan receptor,
such as TR4, may play an important part in the signaling pathway
in human keratinocytes, possibly providing new insights into
keratinocyte biology.
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